Home
/
International Stem Cell CORP
/
Financials
/
Quarterly
International Stem Cell CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that International Stem Cell CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$2.63M
May 21, 2018
Q3
2017
Sep 30, 2017
$1.85M
Nov 14, 2017
Q2
2017
Jun 30, 2017
$1.76M
Aug 11, 2017
Q1
2018
Mar 31, 2017
$2.01M
May 21, 2018
Q3
2017
Sep 30, 2016
$1.94M
Nov 14, 2017
Q2
2017
Jun 30, 2016
$1.92M
Aug 11, 2017
Q1
2017
Mar 31, 2016
$1.62M
May 15, 2017
Q3
2016
Sep 30, 2015
$2.14M
Nov 14, 2016
Q2
2016
Jun 30, 2015
$1.82M
Aug 15, 2016
Q1
2016
Mar 31, 2015
$1.62M
May 16, 2016
Q3
2015
Sep 30, 2014
$1.96M
Nov 13, 2015
Q2
2015
Jun 30, 2014
$1.59M
Aug 13, 2015
Q1
2015
Mar 31, 2014
$1.65M
May 11, 2015
Q3
2014
Dec 31, 2013
$6.15M
Nov 13, 2014
Q1
2014
Dec 31, 2013
$6.15M
May 13, 2014
Q2
2014
Dec 31, 2013
$6.15M
Aug 8, 2014
Q3
2014
Sep 30, 2013
$1.67M
Nov 13, 2014
Q2
2014
Jun 30, 2013
$1.46M
Aug 8, 2014
Q1
2014
Mar 31, 2013
$1.29M
May 13, 2014
Q3
2013
Sep 30, 2012
$1.19M
Nov 13, 2013
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.37M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$2.45M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$2.13M
May 14, 2025
Q3
2025
Sep 30, 2024
$2.18M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$2.33M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$2.13M
May 14, 2025
Q3
2024
Sep 30, 2023
$1.97M
Nov 13, 2024
Q2
2024
Jun 30, 2023
$1.84M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$2.09M
May 14, 2024
Q3
2023
Sep 30, 2022
$1.70M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$2.03M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$2.02M
May 12, 2023
Q3
2022
Sep 30, 2021
$1.84M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$1.83M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$1.66M
May 13, 2022
Q3
2021
Sep 30, 2020
$1.48M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$1.81M
Aug 13, 2021
Q1
2021
Mar 31, 2020
$2.36M
May 14, 2021
Q3
2020
Sep 30, 2019
$2.10M
Nov 12, 2020
Q2
2020
Jun 30, 2019
$2.32M
Aug 12, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$57.0K
Nov 13, 2025
Q3
2025
Jun 30, 2025
$129.0K
Nov 13, 2025
Q2
2025
Jun 30, 2025
$129.0K
Aug 14, 2025
Q3
2025
Mar 31, 2025
($256.0K)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($256.0K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($256.0K)
May 14, 2025
Q3
2025
Sep 30, 2024
($125.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2024
$119.0K
Aug 14, 2025
Q3
2025
Jun 30, 2024
$119.0K
Nov 13, 2025
Q1
2025
Mar 31, 2024
($214.0K)
May 14, 2025
Q2
2025
Mar 31, 2024
($214.0K)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($214.0K)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($131.0K)
Nov 13, 2024
Q3
2024
Jun 30, 2023
$492.0K
Nov 13, 2024
Q2
2024
Jun 30, 2023
$492.0K
Aug 13, 2024
Q1
2024
Mar 31, 2023
($34.0K)
May 14, 2024
Q3
2024
Mar 31, 2023
($34.0K)
Nov 13, 2024
Q2
2024
Mar 31, 2023
($34.0K)
Aug 13, 2024
Q3
2023
Sep 30, 2022
($343.0K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($2.0K)
Aug 11, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$94.0K
Nov 13, 2025
Q2
2025
Jun 30, 2025
$167.0K
Aug 14, 2025
Q1
2025
Mar 31, 2025
($215.0K)
May 14, 2025
Q3
2025
Sep 30, 2024
($90.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2024
$149.0K
Aug 14, 2025
Q1
2025
Mar 31, 2024
($178.0K)
May 14, 2025
Q3
2024
Sep 30, 2023
($97.0K)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($144.0K)
Aug 13, 2024
Q1
2024
Mar 31, 2023
$2.0K
May 14, 2024
Q3
2023
Sep 30, 2022
($300.0K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
$31.0K
Aug 11, 2023
Q1
2023
Mar 31, 2022
$25.0K
May 12, 2023
Q3
2022
Sep 30, 2021
($623.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($406.0K)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($567.0K)
May 13, 2022
Q3
2021
Sep 30, 2020
($798.0K)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($832.0K)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($455.0K)
May 14, 2021
Q3
2020
Sep 30, 2019
($813.0K)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($941.0K)
Aug 12, 2020